← Back to bills
This bill did not pass parliament19 Feb 2021

The bill was rejected or lapsed before becoming law.

🏛 House of Representatives3 readingsAmendments circulated

Therapeutic Goods Amendment (2020 Measures No. 2) 2020

✦ Plain-English Summary

Therapeutic Goods Amendment (2020 Measures No. 2) Bill 2020

What it does

This law updates the rules for therapeutic goods (medicines and medical devices) in Australia. The main change lets pharmacists swap one prescription medicine for another when the original medicine is in serious short supply — for example, if a particular antibiotic runs out. The bill also introduces a tracking system for medical devices and makes several technical updates to how the government manages medicine approvals and imports.

Why it matters

During shortages (like those that happened during COVID), pharmacists can now help patients get treatment without waiting for the exact medicine their doctor prescribed. This keeps healthcare running more smoothly when supply problems hit.

Key details

  • Pharmacist substitution: Only works when the Health Minister officially declares a serious shortage of a specific medicine in Australia (or a region)
  • Medical device tracking: New system to identify and track medical devices more reliably across the supply chain
  • Staged rollout: Most changes start the day after the law passes, but rules about restricted information (Schedule 5) don't kick in for 2 months, giving businesses time to prepare

Official Description

Amends the Therapeutic Goods Act 1989 to: enable pharmacists to substitute a different medicine for one that has been prescribed where there is a serious scarcity of the prescribed medicine; allow the making of regulations to establish a unique device identification database for the traceability and monitoring of medical devices in Australia; enable authorised employees in the Department of Health to obtain and possess prescription medicines, or unapproved therapeutic goods, without contravening state and territory laws; allow the making of regulations to prohibit the import, export, supply or manufacture of therapeutic goods that are prohibited under international agreements; ensure the timely availability of COVID-19 vaccines by enabling the secretary to consent to the importation and supply of registered or listed therapeutic goods that do not have their registration or listing number on the label; make amendments in relation to the operation of the data protection scheme for assessed listed medicines; and make minor and technical amendments.

Full bill PDF →APH page →

Audit History

Introduced

9 Dec 2020

Last updated on APH

10 Apr 2026

Outcome date

19 Feb 2021

Last checked by Crossbench

4 days ago

Full text indexed

4 days ago

🗳️

No formal division recorded

This bill passed by voice vote — parliament agreed without calling a formal count. A division is only recorded when a member explicitly requests one.

Constituent votes

Voting is closed — this bill has been decided by parliament.

No votes yet.

No votes were recorded for this bill.

🔒 Voting closed — this bill has been decided by parliament